Post-approval studies (Phase 4)Ended earlyNCT00333229
What this trial is testing
Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone Loss
Who this might be right for
Primary Hormone Receptor Negative Breast Cancer in Premenopausal Women
Novartis Pharmaceuticals 11